Defense Secretary Lloyd Austin's medical issues last December put the spotlight on fighting prostate cancer while reducing the risk of side effects and complications. A trial here on a less invasive ...

TIME names NanoKnife one of 2025’s Best Inventions — already treating prostate cancer in Toronto with precise, function-preserving results. TIME's recognition of NanoKnife (IRE) reinforces what we’ve ...

AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...

Treatments for localised prostate cancer have long been aimed at treating the whole prostate, either by surgical removal or by radiotherapy. However ...

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors For the past 25 years, TIME’s Best ...

A greater number of men may be offered electrical prostate cancer treatment to destroy tumours, after NHS watchdogs relaxed its rules. Doctors have previously only been permitted to use the technique, ...

Prostate cancer affects one in every eight men during their lifetime, making it the most prevalent form of cancer for males. For many, the standard of care means facing aggressive treatments that ...

Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors AngioDynamics, Inc. (NASDAQ: ANGO), ...

(MENAFN- EIN Presswire) EINPresswire/ -- TIME Magazine has named the NanoKnife System (IRE) - a minimally invasive prostate cancer treatment - one of the Best Inventions of 2025. At Urology ...